Dick Menzies spends much of his time researching Tuberculosis, Internal medicine, Surgery, Immunology and Meta-analysis. His Tuberculosis research includes themes of Incidence and Drug resistance. The Internal medicine study combines topics in areas such as Serology, Rifampicin and Isoniazid.
His Surgery research is multidisciplinary, relying on both Pyrazinamide, Adverse effect and Ethambutol. His work in Immunology tackles topics such as Predictive value of tests which are related to areas like Forest plot. His Meta-analysis research is multidisciplinary, incorporating perspectives in Receiver operating characteristic, Pharmacotherapy, Lost to follow-up and Clinical trial.
Dick Menzies mostly deals with Tuberculosis, Internal medicine, Latent tuberculosis, Surgery and Tuberculin. Mycobacterium tuberculosis is the focus of his Tuberculosis research. He combines subjects such as Rifampicin and Isoniazid with his study of Internal medicine.
His Latent tuberculosis research includes elements of Clinical trial, Health care and Family medicine. Dick Menzies has included themes like Pyrazinamide, Ethambutol, Cohort study, Confidence interval and Pharmacotherapy in his Surgery study. The various areas that Dick Menzies examines in his Tuberculin study include Skin test, Mass screening, Epidemiology and Vaccination.
His main research concerns Tuberculosis, Internal medicine, Latent tuberculosis, Meta-analysis and Family medicine. His Tuberculosis research incorporates elements of Multiple drug resistance, Incidence, Regimen, Intensive care medicine and Disease. His research in Internal medicine focuses on subjects like Isoniazid, which are connected to Mycobacterium tuberculosis and Rifampicin.
The study incorporates disciplines such as Clinical trial, Intention-to-treat analysis, Health care, Environmental health and Tuberculin in addition to Latent tuberculosis. His work deals with themes such as Observational study, Systematic review, Interferon gamma release assay and Confidence interval, which intersect with Meta-analysis. His Family medicine research incorporates themes from Psychological intervention, Intervention and Public health.
His scientific interests lie mostly in Tuberculosis, Internal medicine, Latent tuberculosis, Meta-analysis and Regimen. His Tuberculosis study combines topics from a wide range of disciplines, such as Machine learning and Causal inference. He interconnects Percentage point and Levofloxacin in the investigation of issues within Internal medicine.
His work carried out in the field of Latent tuberculosis brings together such families of science as Clinical trial, Incidence, Isoniazid, Protocol and Public health. His research in Meta-analysis intersects with topics in Transmission risks and rates, Asymptomatic and Confidence interval. His Regimen study incorporates themes from Receiver operating characteristic, Propensity score matching, Disease and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.
Madhukar Pai;Alice Zwerling;Dick Menzies.
Annals of Internal Medicine (2008)
Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.
Dick Menzies;Madhukar Pai;George Comstock.
Annals of Internal Medicine (2007)
Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis
Daphne Yee;Chantal Valiquette;Marthe Pelletier;Isabelle Parisien.
American Journal of Respiratory and Critical Care Medicine (2003)
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Timothy R. Sterling;M. Elsa Villarino;Andrey S. Borisov;Nong Shang.
The New England Journal of Medicine (2011)
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?
M Farhat;C Greenaway;M Pai;D Menzies.
International Journal of Tuberculosis and Lung Disease (2006)
Tuberculosis among Health-Care Workers in Low- and Middle-Income Countries: A Systematic Review
Rajnish Joshi;Arthur L Reingold;Dick Menzies;Madhukar Pai.
PLOS Medicine (2006)
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies
Sandra Dial;Khalid Alrasadi;Chantal Manoukian;Allen Huang.
Canadian Medical Association Journal (2004)
Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.
American Journal of Respiratory and Critical Care Medicine (1999)
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja;David Ashkin;Monika Avendano;Rita Banerjee.
PLOS Medicine (2012)
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Robert S Wallis;Madhukar Pai;Madhukar Pai;Dick Menzies;Dick Menzies;T Mark Doherty.
The Lancet (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: